small molecule

MUCINEX D

GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE

Loss of exclusivityloss of exclusivity
CompanyRB HEALTH US LLC

Drug detail

Brand nameMUCINEX D
Active ingredientGUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
Strength600MG;60MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJune 2004
Marketing statusOTC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MUCINEX D patent cliff — loss of exclusivity — | CliffBio